Key statistics
On Friday, Pacira Biosciences Inc (82P:DUS) closed at 16.70, 63.73% above the 52 week low of 10.20 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.30 |
---|---|
High | 16.70 |
Low | 16.30 |
Bid | 16.70 |
Offer | 17.00 |
Previous close | 16.50 |
Average volume | 11.67 |
---|---|
Shares outstanding | 46.17m |
Free float | 45.18m |
P/E (TTM) | -- |
Market cap | 802.49m USD |
EPS (TTM) | -2.15 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:31 GMT.
More ▼
- Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
- Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
- Pacira BioSciences Reports Third Quarter 2024 Financial Results
- Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
- Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
- Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
- Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
- Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
More ▼